Dr. Uli Brodl

Testing blockchain technology for clinical trials in Canada

Written by Uli Brödl | Analytics, Blockchain, Data...

By: Dr. Uli Brödl, Vice President, Medical and Regulatory Affairs, Boehringer Ingelheim (Canada) Ltd. The healthcare industry is undergoing significant changes due to the vast amounts of disparate data being generated. There is a huge need for transformative healthcare solutions where healthcare researchers, providers, and patients have access to a 360-degree view of health data. ...read more